Repeat EUS-FNA for Pancreatic Cancer Diagnosis
Author Information
Author(s): Nicaud Mark, Hou Wei, Collins Dennis, Wagh Mihir S., Chauhan Shailendra, Draganov Peter V.
Primary Institution: University of Florida
Hypothesis
The study aims to determine the accuracy of repeat EUS-FNA in patients with suspected pancreatic cancer and prior non-diagnostic EUS-FNA.
Conclusion
Repeat EUS-FNA provides reasonable accuracy and may be worthwhile in patients with suspected pancreatic cancer who had prior negative EUS-FNA.
Supporting Evidence
- Repeat EUS-FNA showed pancreatic mass in 27 patients (96.42%) and no mass in 1 (3.58%).
- FNA was performed in all patients and cytology was positive for malignancy in 6 (21.43%).
- Out of the 28 patients, 17 (60.71%) were eventually confirmed to have cancer.
- Overall repeat EUS-FNA correctly determined the true final status in 17 out of 28 patients providing sensitivity for the diagnosis of cancer of 35%.
- The specificity of repeat EUS-FNA was 100%.
- The overall accuracy of repeat EUS-FNA was 61%.
- The mean number of FNA passes on repeat EUS examination was 4.82.
Takeaway
If doctors think someone might have pancreatic cancer but the first test didn't show anything, doing the test again can help find out if they really have cancer.
Methodology
Retrospective cohort study analyzing patients who underwent repeat EUS-FNA for suspected pancreatic cancer after initial non-diagnostic EUS-FNA.
Potential Biases
The study was conducted by highly experienced endosonographers, which may not reflect the outcomes in less experienced settings.
Limitations
The study was conducted in a single tertiary referral center with a relatively small patient population, which may limit the generalizability of the findings.
Participant Demographics
12 male and 16 female patients, mean age 62 years (range 34–82).
Statistical Information
Confidence Interval
95% CI 14%–62%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website